ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
14 announcements with these filters
Sanjivani Paranteral clarified the objects of its proposed 5 lakh convertible warrant issue to BSE. Proceeds of ~₹5.80 Cr will fund capex and subsidiary working capital for expansion.
Sanjivani Paranteral Limited held its 32nd Annual General Meeting on September 16, 2026. The meeting concluded with resolutions on financial statements and director re-appointment.
Sanjivani Paranteral Limited has filed its Annual Report for the financial year 2025-26 as required under SEBI regulations. The document details the company's annual performance.
Sanjivani Paranteral shareholders approved the issuance of 5,00,000 convertible warrants to promoters on a preferential basis. A material related party transaction with subsidiary SPL Infusion was also cleared.
Sanjivani Paranteral reported Q1 FY27 results, with total income of ₹23.99 Crore and a net profit of ₹2.49 Crore. The company demonstrated strong year-on-year growth across key metrics.
Sanjivani Paranteral Q1 FY27 consolidated revenue grew 33.8% YoY to ₹238.4 Mn, driven by the new Pune IV-fluid plant ramp-up. Transitioning to a multi-vertical platform with injectables, orals, and nutraceuticals.
Sanjivani Paranteral Ltd reported revenue from operations of ₹23.8 Cr (+33.0% YoY) and net profit of ₹2.5 Cr (+47.1% YoY) for Q1 FY27.
Sanjivani Paranteral Ltd has scheduled a board meeting for August 14, 2026, to consider quarterly financial results, the annual report, and the upcoming Annual General Meeting.
Sanjivani Paranteral Ltd issued a Postal Ballot notice to seek shareholder approval for issuing 5,00,000 convertible warrants and approving material related party transactions worth ₹10 Crore.
Sanjivani Paranteral issued a postal ballot notice to seek shareholder approval for issuing 5,00,000 convertible warrants to its promoter, raising ₹7.37 Crore.
Sanjivani Paranteral Ltd approved a preferential issue of 500,000 convertible warrants to Mr. Ashwani Khemka, raising ₹7.37 Crore. The issuance, set for an 18-month conversion window, strengthens capital.
Sanjivani Paranteral's board approved a preferential issue of 5,00,000 fully convertible warrants to a promoter. The issuance aggregates to ₹7.3695 Crore.
Sanjivani Paranteral Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI listing regulations.
Sanjivani Paranteral Limited scheduled a board meeting for July 23, 2026, to discuss a proposal for raising funds through warrants or convertible securities.